Regeneron (United States)
In research, Regeneron (United States) stands highest in Medicine (#728 of 10,443 worldwide), Health Sciences (#1,067 of 11,982 worldwide) and Life Sciences (#882 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Dermatology, Immunology and Immunology and Microbiology — Dermatology is 15.4× its share of world research.
- World rank, 2022–2025
- #1,933 of 28,054 · #1,352 all time
- Rank in United States
- #294 of 4,192
- Research works
- 1.9k ▲ 160% vs 2013–17
- Citations
- 135k 70.0 per fractional work
- Top-10% rate
- 21.0% record average 16.5%
- Open access
- 54% world 28%
What is Regeneron (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #728 of 10,443 | 18.7% | 376 | #733 | |
| Health SciencesDomain | #1,067 of 11,982 | 18.6% | 387 | #984 | |
| Life SciencesDomain | #882 of 7,800 | 27.2% | 218 | #483 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,309 of 3,579 | 28.2% | 138 | #956 | |
| Molecular BiologySubfield | #1,135 of 2,175 | 25.6% | 87 | #625 | |
| Immunology and MicrobiologyField | #457 of 682 | 26.2% | 60 | #756 |
Each strip is that field’s whole ranked pool, with the notch where Regeneron (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#733 #728
- Health Sciences#984 #1,067
- Life Sciences#483 #882
- Biochemistry, Genetics and Molecular Biology#956 #1,309
- Molecular Biology#625 #1,135
- Immunology and Microbiology#756 #457
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Regeneron (United States) specialise in?
Where its research is concentrated relative to its size: Dermatology takes 15.4× the share of its output that it takes of world research.
- DermatologySubfield · 26.8 works15×
- ImmunologySubfield · 58.7 works13×
- Immunology and MicrobiologyField · 60.1 works9.0×
- RheumatologySubfield · 20.3 works6.7×
- PhysiologySubfield · 37.1 works6.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.0×. Every wedge is a field page.
- Immunology and Microbiology 9.0×
- Biochemistry, Genetics and Molecular Biology 3.9×
- Medicine 3.0×
- Pharmacology, Toxicology and Pharmaceutics 1.4×
- Neuroscience 1.3×
- Mathematics 1.2×
- Veterinary 0.9×
- Chemistry 0.7×
- Nursing 0.6×
- Economics, Econometrics and Finance 0.6×
- Health Professions 0.5×
- Decision Sciences 0.4×
- Chemical Engineering 0.1×
- Engineering 0.1×
- Psychology 0.1×
- Dentistry 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Physics and Astronomy 0.1×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Materials Science 0.0×
- Earth and Planetary Sciences 0.0×
- Energy 0.0×
- Arts and Humanities 0.0×
Who are the top researchers at Regeneron (United States)?
Ranked on the composite score, George D. Yancopoulos, Neil M.H. Graham and Israel Lowy lead among researchers whose main affiliation is Regeneron (United States).
- 1 George D. Yancopoulos United States · #1,215 worldwide 2.5k citations · 105 works
- 2 Neil M.H. Graham United States · #11,524 worldwide 735 citations · 49 works
- 3 Israel Lowy United States · #29,349 worldwide 379 citations · 53 works
- 4 Matthew G. Fury United States · #46,103 worldwide 222 citations · 43 works
- 5 Heribert Staudinger United States · #47,713 worldwide 468 citations · 30 works
- 6 Andrew Murphy United States · #51,764 worldwide 406 citations · 46 works
- 7 Stanley J. Wiegand United States · #55,364 worldwide 410 citations · 32 works
- 8 Neil Stahl United States · #73,387 worldwide 604 citations · 25 works
- 9 Jeffrey G. Reid United States · #79,299 worldwide 372 citations · 25 works
- 10 Elizabeth Laws United States · #80,786 worldwide 194 citations · 36 works
Which keywords describe research at Regeneron (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Monoclonal Antibodies, Inflammation, Therapeutic Antibodies, Treatment, Glycosylation, Diagnosis and Management.
- Chimeric Antigen Receptor
- Leukemia
- Gene Therapy
- Regulatory T Cells
- Children
- Filaggrin
- Refolding
- Stability
- Protein Aggregation
- Lymphoma
- Eosinophils
- Clinical Trials
- Fc Receptors
- Quality of Life
- Immunogenicity
- Asthma
- Management
- Diagnosis
- Treatment
- Inflammation
- Epidemiology
- Monoclonal Antibodies
- Therapeutic Antibodies
- Glycosylation
- Biopharmaceuticals
- Genetics
- Immunotherapy
- Antibody Engineering
- Immunology
- Allergic Diseases
- Recombinant Proteins
- Cancer Immunotherapy
- Immune Dysregulation
- Chromatography
- Staphylococcus aureus
- Skin Microbiome
- Guidelines
- Tumor Regression
- Inflammatory Diseases
- CAR T Cells
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology91▲ 3.5×74 topics
- Inflammation64▲ 4.7×65 topics
- Monoclonal Antibodies58▲ 99×3 topics
- Treatment52▲ 6.5×31 topics
- Therapeutic Antibodies50▲ 108×2 topics
- Diagnosis44▲ 7.2×25 topics
- Glycosylation44▲ 60×3 topics
- Management37▲ 7.2×16 topics
- Biopharmaceuticals33▲ 98×3 topics
- Asthma33▲ 51×2 topics
- Genetics32▲ 6.8×14 topics
- Immunogenicity31▲ 108×3 topics
- Immunotherapy28▲ 6.0×19 topics
- Quality of Life28▲ 3.0×22 topics
- Antibody Engineering28▲ 77×1 topic
- Fc Receptors28▲ 77×1 topic
- Immunology26▲ 37×2 topics
- Clinical Trials25▲ 5.7×14 topics
- Allergic Diseases25▲ 65×1 topic
- Eosinophils25▲ 65×1 topic
- Recombinant Proteins25▲ 119×2 topics
- Lymphoma24▲ 23×4 topics
- Cancer Immunotherapy24▲ 24×3 topics
- Protein Aggregation24▲ 68×3 topics
- Immune Dysregulation22▲ 43×2 topics
- Stability22▲ 15×2 topics
- Chromatography22▲ 222×1 topic
- Refolding22▲ 222×1 topic
- Staphylococcus aureus22▲ 44×2 topics
- Filaggrin22▲ 67×1 topic
- Skin Microbiome22▲ 67×1 topic
- Children22▲ 14×3 topics
- Guidelines20▲ 6.6×9 topics
- Regulatory T Cells19▲ 25×4 topics
- Tumor Regression18▲ 25×2 topics
- Gene Therapy18▲ 14×6 topics
- Inflammatory Diseases18▲ 15×4 topics
- Leukemia18▲ 32×2 topics
- CAR T Cells17▲ 35×1 topic
- Chimeric Antigen Receptor17▲ 35×1 topic
Which research topics does Regeneron (United States) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Asthma and respiratory diseases, Protein purification and stability and Dermatology and Skin Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 28 works
- 2 Asthma and respiratory diseases Physiology 25 works
- 3 Protein purification and stability Molecular Biology 22 works
- 4 Dermatology and Skin Diseases Dermatology 22 works
- 5 CAR-T cell therapy research Oncology 17 works
- 6 Eosinophilic Esophagitis Surgery 16 works
- 7 IL-33, ST2, and ILC Pathways Immunology 14 works
- 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 12 works
- 9 Cancer Immunotherapy and Biomarkers Oncology 12 works
- 10 Virus-based gene therapy research Genetics 9 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Regeneron (United States)'s research output changed?
Output in 2018–2022 was 160% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tarrytown
- Mental Health Association of Westchester County
- Psychogenics (United States)
- Progenics Pharmaceuticals (United States)
- Araim Pharmaceuticals (United States)
- Restorix Health
- ARMGO Pharma (United States)
- Stone Barns Center for Food & Agriculture
- Historic Hudson Valley
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.